Position in LXRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$131,964
+$26,624 QoQ
Shares Held
54,985
-18.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#68
of 148 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026R Squared Ltd holds $4,187,945 across 33 Biotechnology names. LXRX ranks #10 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,337 | $664,128 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
902 | $562,433 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
5,313 | $421,267 | |
| 4 | MRNA |
Moderna, Inc.
|
5,647 | $395,459 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
15,246 | $257,962 | |
| 6 | BLTE |
Belite Bio, Inc
|
1,338 | $206,031 | |
| 7 | CYTK |
Cytokinetics Inc
|
2,350 | $200,196 | |
| 8 | MESO |
Mesoblast Ltd
|
14,492 | $196,076 |
All Filings in LXRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,964 | 54,985 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $105,340 | 67,526 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $53,565 | 46,579 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $43,266 | 32,049 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $28,081 | 29,559 | Shares | Sole | 2025-07-31 | |
| 2024-12-31 | $2,249 | 3,040 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||